BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12101671)

  • 41. [P27 expression and survival in NSCLC].
    Hirabayashi H
    Nihon Rinsho; 2002 May; 60 Suppl 5():263-6. PubMed ID: 12101669
    [No Abstract]   [Full Text] [Related]  

  • 42. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
    Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
    Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
    Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
    Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
    Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer.
    Cağlayan B; Fidan A; Salepçi B; Kiral N; Torun E; Salepçi T; Mayadağli A
    Tuberk Toraks; 2004; 52(4):323-32. PubMed ID: 15558354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of pleural lavage cytology after thoracotomy and before closure of the chest in lung cancer.
    Taniguchi Y; Nakamura H; Miwa K; Adachi Y; Fujioka S; Haruki T; Horie Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):102-6. PubMed ID: 19401295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-regulatory cells in COPD or tumour environment.
    Domagala-Kulawik J; Maskey-Warzecowska M
    Eur Respir J; 2009 Jul; 34(1):284; author reply 285-6. PubMed ID: 19567614
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunobiology of the non-small-cell lung carcinoma: new aspects].
    Fischer JR; Neuner A; Muley T; Lahm H; Drings P
    Onkologie; 2001 Sep; 24 Suppl 5():72-4. PubMed ID: 11600817
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of prognostic factors on endpoints for clinical studies.
    Sørensen JB
    Lung Cancer; 1994 Nov; 11 Suppl 3():S45-54. PubMed ID: 7704512
    [No Abstract]   [Full Text] [Related]  

  • 52. Small cell lung cancer: sex and survival.
    Yesner R
    Arch Pathol Lab Med; 2007 Nov; 131(11):1631-3. PubMed ID: 17979476
    [No Abstract]   [Full Text] [Related]  

  • 53. Folate receptor alpha: a new tool in the diagnosis and treatment of lung cancer.
    Wood LD
    Oncotarget; 2012 Jul; 3(7):668-9. PubMed ID: 22914202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is MPV a real prognostic indicator for non-small cell lung cancer?
    Ozyalvacli G; Yasar Z
    Asian Pac J Cancer Prev; 2014; 15(18):8003. PubMed ID: 25292103
    [No Abstract]   [Full Text] [Related]  

  • 55. In survival curves is the P-value enough?
    Marino P
    Lung Cancer; 1995 Mar; 12(1-2):87-9. PubMed ID: 7600035
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic factors in non small cells lung cancer.
    Garcia AL
    Port J Card Thorac Vasc Surg; 2023 Apr; 30(1):9-10. PubMed ID: 37029934
    [No Abstract]   [Full Text] [Related]  

  • 57. A lung cancer molecular prognostic test ready for prime time.
    Xie Y; Minna JD
    Lancet; 2012 Mar; 379(9818):785-7. PubMed ID: 22386017
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinicopathological conference; neurofibroma of lung, with cystic degeneration and rupture into the pleural cavity.
    BALDWIN LB; BRUES A; SWEET R
    Ariz Med; 1951 Nov; 8(11):52-9. PubMed ID: 14886242
    [No Abstract]   [Full Text] [Related]  

  • 59. Prognostic tests in cancer of the lung: fact and fallacy.
    Braeman J
    Med Hypotheses; 1975; 1(5):176-7. PubMed ID: 1214675
    [No Abstract]   [Full Text] [Related]  

  • 60. Lung cancer: diagnosis and survival.
    Brett GZ
    Br Med J; 1970 Feb; 1(5695):566. PubMed ID: 5435207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.